GHK-Cu
Research peptideCopper tripeptide · collagen and firmness with human evidence · anti-inflammatory and repair beyond the skin
Overview
What has it been researched for?
- Closes wounds and ulcers Main focusEarly evidence
- Firmer, denser skin: more collagenEarly evidence
- Antioxidant: less oxidative stressEarly evidence
- Lowers inflammationEarly evidence
- Nerve regenerationEarly evidence
- Protects the lungEarly evidence
- Denser hair, less sheddingEarly evidence
- Cellular longevity: sirtuins and repairEarly evidence
Research protocols
The SBL research protocol and what the literature reports. Not medical advice.
SBL research protocol · no established clinical regimen in people
- Dose
- 1 → 2 mg
- Frequency
- diario
- Duration
- 12 weeks
- Route
- Subcutaneous
- Evidence level
- Extrapolated
Tools
Evidence and studies
See studies →Protocols
Research protocols
SBL research protocol · no established clinical regimen in people
Research use, with no established clinical regimen in people.
- Dose
- 1 → 2 mg
- Frequency
- diario
- Timing
- noche
- Duration
- 12 weeks
- Break
- 4 weeks
- Route
- Subcutaneous
- Evidence level
- Extrapolated
Example dose
30-unit U-100 insulin syringe · Starting dose of its protocol, with 3 ml of water in the 50 mg vial.
30-unit U-100 insulin syringe · Starting dose of its protocol, with 3 ml of water in the 100 mg vial.
What it pairs with
- Glowdoes not pair
- Klowdoes not pair
- Glutathionepairs well
Preparation and dosing
Quick reference
Preparation
- Diluent
- Bacteriostatic water
Evidence
Each effect with its evidence level and, where available, its source.
- Closes wounds and ulcersExtrapolatedSee study · 1994
- Firmer, denser skin: more collagenExtrapolatedSee study · 2015
- Antioxidant: less oxidative stressPreclinicalSee study · 2012
- Lowers inflammationPreclinicalSee study · 2025
- Nerve regenerationPreclinicalSee study · 2005
- Protects the lungPreclinicalSee study · 2022
- Denser hair, less sheddingExtrapolatedSee study · 2016
- Cellular longevity: sirtuins and repairPreclinicalSee study · 2018
The science
Mechanisms, studies and references
Copper tripeptide
Safety
It makes sense if you want
- Skin healing & regeneration
- Firmer, more radiant skin
- General body recovery
It does not make sense if
- Active cancer or oncology treatment in the last 5 years
- Pregnancy or breastfeeding
- Wilson disease or copper allergy
- Severe liver impairment
Talk to your doctor first if this applies (1)
- Liver disease
The certificate of analysis (CoA) certifies the identity and purity of the batch. It does not certify safety of use.
Verify your batch →For research use only (RUO). This consult is educational and does not replace your doctor.
Questions
Frequently asked questions
What is it reconstituted with, and how much?
With bacteriostatic water: 3 ml into the 50 mg vial, giving 16.67 mg/ml.
What is the starting dose of the research protocol?
1 → 2 mg, diario. This is the SBL research protocol, with no established clinical regimen in people.
How long is the cycle, and how long does a vial last?
12 weeks ON / 4 weeks OFF. At the starting dose, the 50 mg vial lasts ~4 sem.
Which route is used in research?
Subcutaneous.
When does it make no sense?
It makes no sense with: Active cancer or oncology treatment in the last 5 years, Pregnancy or breastfeeding, Wilson disease or copper allergy, Severe liver impairment. Details in the Safety tab.
What is it combined with?
It goes well with Glutathione. The reasons are in the Protocols tab.
How do I check my batch?
With the code on the vial, in the verifier. The CoA certifies the identity and purity of the batch, not safety of use.
For research use only (RUO). This consult is educational and does not replace your doctor.